Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2003
08/26/2003US6610299 Glycosyl-etoposide prodrugs, a process for the preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates for treating cancers.
08/26/2003US6610298 Molecular conjugate comprising (a) a photosensitizer and (b) a targeting moiety, wherein the targeting moiety targets the conjugate to the intracellular pathogen or to an infected host cell.
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610283 Poly(diallylamine)-based bile acid sequestrants
08/26/2003US6610281 Polyether modified with sulfone compound; immobilizing biomass
08/26/2003US6610273 Container is provided with a non-metal interior surface so as to reduce chemical degradation
08/26/2003US6610272 Medicinal aerosol formulation comprising pioglitazone hydrochloride and a protective colloid amino acid stabilizer
08/26/2003US6610271 System and method for intranasal administration of lorazepam
08/26/2003US6610269 Disease state imaged using a targeted contrast agent of the formula V-L-R, where V is a vector moiety having affinity for an angiogenesis-related endothelial cell receptor, L is a linker, R is a macromolecular or particulate label
08/26/2003US6610266 Calcium metasilicates and methods for making
08/26/2003CA2309033C Lacrimal gland specific emulsions for topical application to ocular tissue
08/21/2003WO2003069306A2 Protein carrier system for therapeutic oligonucleotides
08/21/2003WO2003068942A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses
08/21/2003WO2003068936A2 Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds
08/21/2003WO2003068934A2 Chimeric molecules for cleavage in a treated host
08/21/2003WO2003068925A2 Production of a protein delivery system for in vivo therapeutic treatment
08/21/2003WO2003068843A1 Glucosamine-polyacrylate inter-polymer complex and applications thereof
08/21/2003WO2003068809A2 An herpes simplex virus complex
08/21/2003WO2003068805A2 Formulation strategies in stabilizing peptides in organic solvents and in dried states
08/21/2003WO2003068722A1 Carboxylic acid compounds for use as surfactants
08/21/2003WO2003068281A1 Composition for skin healing comprising a chitosan hydrogel
08/21/2003WO2003068270A1 Method of radio-labelling biomolecules
08/21/2003WO2003068268A2 Treatment, diagnosis and imaging of disease
08/21/2003WO2003068267A1 Composition for oral or rectal administration
08/21/2003WO2003068266A1 Oral solid solution formulation of a poorly water-soluble active substance
08/21/2003WO2003068264A1 New medicinal compositions on the basis of anticholinergic agents and egfr kinase inhibitors
08/21/2003WO2003068260A1 Antibody-containing solution pharmaceuticals
08/21/2003WO2003068259A1 Antibody-containing solution pharmaceuticals
08/21/2003WO2003068254A1 Glycosaminoglycan-dnase combination therapy
08/21/2003WO2003068253A1 Methods and compositions for the treatment of eye diseases
08/21/2003WO2003068247A1 Eye installation based on iodine anions
08/21/2003WO2003068246A2 Improvements in or relating to compositions
08/21/2003WO2003068241A1 Percutaneous preparations
08/21/2003WO2003068239A1 Novel drugs for external use
08/21/2003WO2003068238A1 Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom
08/21/2003WO2003068209A1 Metformin salts of lipophilic acids
08/21/2003WO2003068201A2 High affinity antibody having a tcr-like specificity and use in detection and treatment
08/21/2003WO2003068196A1 Colonic release composition
08/21/2003WO2003068195A1 Oral dosage form for controlled drug release
08/21/2003WO2003068194A1 Tablets having improved tabletting characteristics and process for producing the same
08/21/2003WO2003068193A1 Pharmaceutical composition comprising n- ((1-n-butyl-4-piperidinyl) methyl)-3, 4-dihydro-2h- (1, 3) oxazino (3, 2-a) indole-10-carboxamide or salt and process therefor comprising dry granulation
08/21/2003WO2003068192A1 Depot medicament, carrier materials for depot medicaments, and method for the production thereof
08/21/2003WO2003068191A1 Formulations of atorvastatin stabilized with alkali metal additions
08/21/2003WO2003068190A1 Intracellular delivery of therapeutic agents
08/21/2003WO2003068188A1 Combination therapy for respiratory disorders
08/21/2003WO2003068187A1 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
08/21/2003WO2003068185A2 Use of buckysome or carbon nanotube for drug delivery
08/21/2003WO2003068169A2 Stabilized synthetic immunogen delivery system
08/21/2003WO2003068166A2 Treatment of ophthalmic disorders using urea and urea derivatives
08/21/2003WO2003068161A2 Composition and method for protecting labile active components
08/21/2003WO2003068144A2 Cytotoxic agents
08/21/2003WO2003068008A1 Water-dispersible coenzyme q10 dry powders
08/21/2003WO2003067988A1 Aqueous antiseptic based on bispyridiniumalkanes
08/21/2003WO2003067952A2 Glucosamine-polyacrylate inter-polymer complex and applications thereof
08/21/2003WO2003060142A9 Compositions and methods for controlled release
08/21/2003WO2003044056A3 Chemically-modified human growth hormone conjugates
08/21/2003WO2003039479A3 Polymeric thiol-linked prodrugs
08/21/2003WO2003030862A3 Anaesthetic compositions and method for their administration
08/21/2003WO2003026481A3 Optically-absorbing nanoparticles for enhanced tissue repair
08/21/2003WO2003020751A3 Homing peptides
08/21/2003WO2003015708A8 Composition and method for treating hiv infection
08/21/2003WO2003006070A3 Improved chelator conjugates
08/21/2003WO2002098459A3 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS
08/21/2003WO2002095027A3 Immunostimulatory oligodeoxynucleic molecules
08/21/2003WO2002089917A3 Dermatological formulations
08/21/2003WO2002089739A3 Peptide deformylase activated prodrugs
08/21/2003WO2002088664A3 Control of compactability through crystallization
08/21/2003WO2002085384A3 Lubricious coatings for substrates
08/21/2003WO2002085311A3 Hcg formulation
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003WO2002053174A3 Controlled release pharmaceutical systems
08/21/2003WO2002044324A3 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
08/21/2003WO2002043773A3 Tissue specific prodrugs
08/21/2003WO2002020722A9 Methods and compositions for in vitro targeting
08/21/2003WO2002020047A9 Chlamydial peptides and their mimics in demyelinating disease
08/21/2003WO2001094641A3 Gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas
08/21/2003US20030158598 System for sustained-release delivery of anti-inflammatory agents from a coated medical device
08/21/2003US20030158392 IP-10/Mig receptor designated CXCR3, antibodies, nucleic acids, and methods of use therefor
08/21/2003US20030158390 Protein; Escherichia culture product; genetic engineering; fusion
08/21/2003US20030158389 Immunoglobulins; genetic engineering
08/21/2003US20030158375 Neutrophil stimulant; granulocyte colony stimulating factor; genetic engineering
08/21/2003US20030158333 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith
08/21/2003US20030158302 Liquid component of polycationic polymer such as chitosan, and an organic monophosphate source; solid component of calcium, fluoride, strontium, carbonate or phosphate salts; bone repair
08/21/2003US20030158254 Linking an agent to a conjugate moiety that has a greater Vmax for a transporter expressed in plasma membranes of epithelial cells lining a human colon than the agent alone; delayed or sustained release
08/21/2003US20030158244 Methods of treatment using a gastric retained losartan dosage
08/21/2003US20030158242 Salt with a sugar substitute, especially saccharin, cyclamate or acesulfame.
08/21/2003US20030158158 1 alpha, 25-dihydroxy-22-oxavitamin D3 (OCT) and a pH modifier, excellent stability; in vitro differentiation inducing activity, useful for treating secondary hyperparathyroidism, psoriasis and other diseases
08/21/2003US20030158145 6-((2,2- diphenylethyl)amino)-9-(N-ethyl- beta -D-ribofuranosyluronamide)-N--(2-(N'-(1-(2-pyridyl)-4 -piperidyl)ureido)ethyl)-9H-purine-2-carboxamide
08/21/2003US20030158122 For treatment of hyperlipidemia and blood coagulation disorders and to reduce levels of virus, bacteria, and endotoxins in blood stream
08/21/2003US20030158107 Preparation of a therapeutic composition
08/21/2003US20030158097 P-glycoprotein modifier-containing medicinal compositions to be delivered to the large intestine
08/21/2003US20030158089 Administering conjugates comprising a therapeutic agent (e.g., a drug) which is linked to a conjugate moiety that is itself, or itself in combination with the agent, is a good substrate for the sodium dependent multi-vitamin transporter
08/21/2003US20030158087 Novel use of fulmonary surfactant for the prophylaxis or early treatment if acute fulmonary diseases
08/21/2003US20030157690 Fusion protein delivery system and uses thereof
08/21/2003US20030157669 Ansamitocins
08/21/2003US20030157641 Polycistronic expression of antibodies
08/21/2003US20030157561 Combinatorial libraries of monomer domains
08/21/2003US20030157487 Nucleic acid ligands
08/21/2003US20030157479 Antigen arrays for treatment of allergic eosinophilic diseases
08/21/2003US20030157200 Use of oligosaccharides to stimulate beta-endorphin production
1 ... 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 ... 1712